GLP-1 Coverage Is Rising: How Can Employers Prepare?

Demand for GLP-1 medications is strong and shows no signs of diminishing. Initially developed for diabetes, GLP-1s have grown in popularity thanks, in part, to their effectiveness at addressing obesity - a disease that has the largest impact on healthcare costs for nearly 25% of U.S. employers. Currently, one in three employers offer GLP-1 coverage for diabetes and weight loss, and more are learning that it can do more than address obesity - including prevent employee absenteeism and chronic diseases.

Is your company prepared to offer GLP-1 coverage? This playbook explores how employers can be a part of this new era of weight management - one where employers provide benefits that enable employees to show up more and perform better. Topics include:

• The drivers behind increasing demand for GLP-1s.
• The benefits of offering GLP-1s that extend beyond weight loss.
• The key considerations when offering GLP-1s — and the risks of not providing them.